<DOC>
	<DOCNO>NCT00635843</DOCNO>
	<brief_summary>The purpose clinical trial ass safety effectiveness MAVERICK™ Total Disc Replacement method treat patient lumbar degenerative disc disease one level L4-S1 , overall success primary endpoint clinical trial . The primary objective show non-inferiority investigational device control treatment . If non-inferiority establish , superiority examine .</brief_summary>
	<brief_title>MAVERICK™ Total Disc Replacement- Pivotal Study</brief_title>
	<detailed_description>For clinical trial , two treatment group , i.e. , investigational patient receive MAVERICK™ Total Disc Replacement control patient receive anterior lumbar interbody fusion procedure INFUSE® Bone Graft/LT-CAGE® Lumbar Tapered Fusion Device . Each investigational site enroll patient 2:1 investigational : control treatment randomization scheme .</detailed_description>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<mesh_term>Spinal Diseases</mesh_term>
	<criteria>Has DDD note back pain discogenic origin , without leg pain , degeneration disc confirm patient history Has 1 follow document CT , MRI , plain xrays : modic change , high intensity zone annulus , loss disc height , decrease hydration disc Has document annular pathology Has singlelevel symptomatic degenerative involvement L4S1 require surgical treatment Has intact facet joint involve vertebral level document CT and/or MRI Has preop Oswestry score≥30 Has preop back pain score ≥20 Age 18 70 yr skeletally , mature , inclusive Has respond nonoperative treatment 6 mo If childbearing potential , patient nonpregnant , nonnursing , agree become pregnant 1 yr surgery Is willing able comply study plan sign Patient Informed Consent Form Has primary diagnosis spinal disorder DDD involve level Had previous posterior lumbar spinal fusion surgical procedure involve level Had prior posterior lumbar surgery result significant muscle/ligament morbidity , include facet save technique Had previous anterior lumbar spinal surgery involve level Requires spinal fusion and/or arthroplasty 1 lumbar level Has severe pathology facet joint involve vertebral body Has posterior element insufficiency Has spondylolisthesis Has spinal canal stenosis Has rotatory scoliosis involve level Level treat fracture secondary trauma Has following may associate diagnosis osteoporosis ( Yes , DEXA Scan require ) : Postmenopausal NonBlack female 60 yrs age weigh less 140 pound ; Postmenopausal female sustain nontraumatic hip , spine wrist fracture ; Male age 60 sustain nontraumatic hip spine fracture . If level BMD 3.5 low 2.5 low vertebral crush fracture , patient exclude Has fever ( temp &gt; 101°F oral ) time surgery Has condition require postop medication interfere fusion , steroid prolong use nonsteroidal antiinflammatory drug , exclude routine perioperative , nonsteroidal antiinflammatory drug . Does include low dose aspirin prophylactic anticoagulation Has overt active bacterial infection , either local systemic and/or potential bacteremia Has presence prior history malignancy ( except basal cell carcinoma skin ) Has document metal allergy , titanium alloy intolerance cobaltchromemolybdenum alloy Is mentally incompetent . If questionable , obtain psych consult Has Waddell Signs Inorganic Behavior score 3 great Has chronic acute renal and/or hepatic failure prior history renal and/or hepatic parenchymal disease Is prisoner Is pregnant Is alcohol and/or drug abuser define currently undergo treatment alcohol and/or drug abuse Has receive drug may interfere bone metabolism within 2 week prior surgery date , exclude routine perioperative , nonsteroidal antiinflammatory drug Has history autoimmune disease Has history exposure injectable collagen implant Has history hypersensitivity protein pharmaceutical ( monoclonal antibody gamma globulin ) collagen Has receive treatment investigational therapy within 30 day prior implantation surgery treatment plan 24 month follow implantation surgery Has receive previous exposure any/all BMP 's either human animal extraction Has history allergy bovine product history anaphylaxis Has history endocrine metabolic disorder know affect osteogenesis Has disease would preclude accurate clinical evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Lumbar degenerative disc disease one level L4-S1</keyword>
</DOC>